Page last updated: 2024-08-23

gepirone and flesinoxan

gepirone has been researched along with flesinoxan in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kelder, D; Ross, SB	1
Etemad, B; Garcia-Espana, JF; Khalid-Khan, S; Rickels, K; Rynn, M	1

Other Studies

2 other study(ies) available for gepirone and flesinoxan

Article	Year
Long lasting attenuation of 8-OH-DPAT-induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist. Naunyn-Schmiedeberg's archives of pharmacology, 1992, Volume: 346, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Corticosterone; Drug Interactions; Hydrocortisone; Injections; Male; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Serotonin Receptor Agonists; Time Factors	1992
Early response and 8-week treatment outcome in GAD. Depression and anxiety, 2006, Volume: 23, Issue:8 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Pyrimidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome	2006

Article

Year

Long lasting attenuation of 8-OH-DPAT-induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist.

Naunyn-Schmiedeberg's archives of pharmacology, 1992, Volume: 346, Issue:2

Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Corticosterone; Drug Interactions; Hydrocortisone; Injections; Male; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Serotonin Receptor Agonists; Time Factors

1992

Early response and 8-week treatment outcome in GAD.

Depression and anxiety, 2006, Volume: 23, Issue:8

Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Pyrimidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome

2006